A Phase I Study of an Anti-GD3 Monoclonal Antibody, KW-2871, in Patients withMetastatic Melanoma.

Details

Language :

English

ISSN :

10849785

Volume :

21

Issue :

6

Database :

Complementary Index

Journal :

Cancer Biotherapy & Radiopharmaceuticals

Publication Type :

Academic Journal

Accession number :

23829490

Full Text :

https://doi.org/10.1089/cbr.2006.21.561